• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Evonik Expands Birmingham, Alabama, Competence Center

Germany-based Evonik Corp. will add extensive manufacturing and R&D capabilities at its Competence Center labs in Birmingham, Alabama. The company plans to create more than 50 high-paying jobs.

According to state officials, following $50 million in investments over the past four years, the Birmingham site is now home to Evonik’s global Competence Center for Medical Devices, which aims to develop new system solutions for medical technology and to expand the competencies of Evonik in the areas of biomaterials and medical polymers.

In addition, the company said it is installing a new, high-speed fill line for its extended-release drug delivery business, which focuses on polymer-based microparticles administered through injection or IV.

Evonik has also begun construction of a new RESOMER-brand polymers production facility adjacent to its existing Birmingham location. The new facility will increase production of bioresorbable polymers and add new production clean rooms and a pilot unit for contract polymer research projects.

“Evonik’s investments in the Birmingham site reflect its commitment to the medical device and drug delivery business as well as the city of Birmingham and its history of world-class medical research and technology,” said Kel Boisvert, Evonik’s Site Manager.

“Evonik is making a significant investment to expand its R&D activities and manufacturing operation in Birmingham, which demonstrates the high level of confidence this global company has in its facility in the city,” Governor Kay Ivey said.

Evonik said the fill line and RESOMER plant are expected to be up and running in the second half of 2018. These polymers are used to formulate extended release parenteral drug delivery systems and to manufacture bioresorbable medical devices such as plates and screws for trauma and orthopedic applications, as well as bioresorbable stents and coatings for next-generation cardiovascular treatments.

“Evonik and its predecessor companies have been active in Alabama for more than 40 years, and we have thrived thanks to the skilled workforce and business-friendly environment here,” said John Rolando, President of Evonik North America.

The company worked closely with the Alabama Department of Commerce, City of Birmingham, Jefferson County and the Birmingham Business Alliance to move forward with the expansion.

“Evonik’s decision to expand its work on highly advanced drug delivery systems in Birmingham is a testament to the talented workforce and broad capabilities that the city offers in the bioscience realm,” said Greg Canfield, Secretary of the Alabama Department of Commerce.

“We have developed a long-standing partnership with Evonik over the years, and we’re committed to supporting the company as it carries out this significant expansion project.”


Exclusive Research